216 related articles for article (PubMed ID: 38264668)
1. A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal
Haldar R; Dhar A; Ganguli D; Chakraborty S; Pal A; Banik G; Miyoshi SI; Das S
Front Immunol; 2023; 14():1304170. PubMed ID: 38264668
[TBL] [Abstract][Full Text] [Related]
2. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
3. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.
Boyd MA; Tennant SM; Saague VA; Simon R; Muhsen K; Ramachandran G; Cross AS; Galen JE; Pasetti MF; Levine MM
Clin Vaccine Immunol; 2014 May; 21(5):712-21. PubMed ID: 24623629
[TBL] [Abstract][Full Text] [Related]
5. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses.
Das S; Chowdhury R; Ghosh S; Das S
Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115
[TBL] [Abstract][Full Text] [Related]
6. An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.
Ghosh S; Chakraborty K; Nagaraja T; Basak S; Koley H; Dutta S; Mitra U; Das S
Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3348-53. PubMed ID: 21300870
[TBL] [Abstract][Full Text] [Related]
7. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
8. Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice.
Halder P; Maiti S; Banerjee S; Das S; Dutta M; Dutta S; Koley H
Vaccine; 2023 Sep; 41(41):5994-6007. PubMed ID: 37625993
[TBL] [Abstract][Full Text] [Related]
9. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers.
Verma S; Singh K; Bansal A
Pharmacol Res; 2021 Jul; 169():105652. PubMed ID: 33975015
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal
Baliban SM; Allen JC; Curtis B; Amin MN; Lees A; Rao RN; Naidu G; Venkatesan R; Rao DY; Mohan VK; Ella KM; Levine MM; Simon R
Molecules; 2018 Jul; 23(7):. PubMed ID: 30018230
[TBL] [Abstract][Full Text] [Related]
11. IgA and IgG1 Specific to Vi Polysaccharide of
Dahora LC; Jin C; Spreng RL; Feely F; Mathura R; Seaton KE; Zhang L; Hill J; Jones E; Alam SM; Dennison SM; Pollard AJ; Tomaras GD
Front Immunol; 2019; 10():2582. PubMed ID: 31781100
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic analysis between typhoidal and non-typhoidal Salmonella serovars reveals typhoid-specific protein families.
Zou QH; Li RQ; Liu GR; Liu SL
Infect Genet Evol; 2014 Aug; 26():295-302. PubMed ID: 24951835
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
Pakkanen SH; Kantele JM; Herzog C; Kantele A
Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
[TBL] [Abstract][Full Text] [Related]
14. Multiple immunodominant O-epitopes co-expression in live attenuated Salmonella serovars induce cross-protective immune responses against S. Paratyphi A, S. Typhimurium and S. Enteritidis.
Li P; Zhang K; Lei T; Zhou Z; Luo H
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010866. PubMed ID: 36228043
[TBL] [Abstract][Full Text] [Related]
15. Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.
Simon R; Wang JY; Boyd MA; Tulapurkar ME; Ramachandran G; Tennant SM; Pasetti M; Galen JE; Levine MM
PLoS One; 2013; 8(5):e64680. PubMed ID: 23741368
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatic approach employing modeling and simulation to design a novel vaccine construct targeting MDR efflux pumps to confer wide protection against typhoidal
Mahapatra SR; Dey J; Kushwaha GS; Puhan P; Mohakud NK; Panda SK; Lata S; Misra N; Suar M
J Biomol Struct Dyn; 2022; 40(22):11809-11821. PubMed ID: 34463211
[TBL] [Abstract][Full Text] [Related]
17. Potential of a novel flagellin epitope as a broad-spectrum vaccine candidate against enteric fever.
Vij S; Thakur R; Kumari L; Suri CR; Rishi P
Microb Pathog; 2023 Jan; 174():105936. PubMed ID: 36494021
[TBL] [Abstract][Full Text] [Related]
18. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
[TBL] [Abstract][Full Text] [Related]
19. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against
Fiorino F; Rondini S; Micoli F; Lanzilao L; Alfini R; Mancini F; MacLennan CA; Medaglini D
Front Immunol; 2017; 8():168. PubMed ID: 28289411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
